Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(8):716-718; doi:10.1093/jnci/91.8.716
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Raderer, M.
Right arrow Articles by Virgolini, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raderer, M.
Right arrow Articles by Virgolini, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 8, 716-718, April 21, 1999
© 1999 Oxford University Press

BRIEF COMMUNICATIONS

Somatostatin Receptor Expression in Primary Gastric Versus Nongastric Extranodal B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type

Markus Raderer, Julia Valencak, Franz Pfeffel, Johannes Drach, Thomas Pangerl, Amir Kurtaran, Michael Hejna, Friedrich Vorbeck, Andreas Chott, Irene Virgolini

Affiliations of authors: M. Raderer, J. Valencak, J. Drach, M. Hejna (Department of Internal Medicine I), F. Pfeffel (Department of Internal Medicine IV), T. Pangerl, A. Kurtaran, I. Virgolini (Department of Nuclear Medicine), F. Vorbeck (Department of Radiology), A. Chott (Department of Pathology), University of Vienna, Austria

Correspondence to: Markus Raderer, M.D., Department of Internal Medicine I, Division of Oncology, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria (e-mail: markus.raderer@akh-wien.ac.at).

Lymphoma of the mucosa-associated lymphoid tissue (MALT) type represents a distinct clinicopathologic entity (1,2). The majority of these lymphomas occur in the stomach, but they may also be found in the thyroid and salivary glands, lung, breast, and ocular adnexa where they tend to remain localized for a prolonged period of time (3). Before therapy is initiated for these lymphomas, there is widespread consensus about the importance of thorough staging, including otolaryngologic investigation, computerized tomography of the abdomen and thorax, gastroscopy, endosonography, colonoscopy, as well as enteroclysis and bone marrow biopsy (4), since stage influences prognosis and choice of therapeutic strategies (5,6). Although endosonography is highly sensitive for focal penetration and evaluation of regional lymph nodes (7), . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNMHome page
V. A.S.H. Dalm, L. J. Hofland, C. M. Mooy, M. A. Waaijers, P. M. van Koetsveld, A. W. Langerak, F. T.J. Staal, A.-J. van der Lely, S. W.J. Lamberts, and M. P. van Hagen
Somatostatin Receptors in Malignant Lymphomas: Targets for Radiotherapy?
J. Nucl. Med., January 1, 2004; 45(1): 8 - 16.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
G. Burggasser, I. Hurtl, W. Hauff, J. Lukas, M. Greifeneder, B. Heydari, A. Thaler, A. Wedrich, and I. Virgolini
Orbital Scintigraphy with the Somatostatin Receptor Tracer 99mTc-P829 in Patients with Graves' Disease
J. Nucl. Med., October 1, 2003; 44(10): 1547 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
P. J. Lugtenburg, B. Löwenberg, R. Valkema, H.-Y. Oei, S. W. Lamberts, M. J. Eijkemans, W. L. van Putten, and E. P. Krenning
Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin's Lymphomas
J. Nucl. Med., February 1, 2001; 42(2): 222 - 229.
[Abstract] [Full Text]